Surviving metastatic non-small cell lung cancer (mNSCLC): The lived experience and supportive care needs of patients (pts) receiving immunotherapy (IT) or targeted therapy (TT).
Julia Elizabeth Lai-Kwon, Sarah Heynemann, Jacinthe Flore, Mary Duffy, Renata Kokanovic, Michael Jefford
Journal of Clinical Oncology | American Society of Clinical Oncology (ASCO) | Published : 2020
e24185 Background: IT and TT have improved survival for many pts with mNSCLC. However, the lived experience of these pts is under-studied. We conducted a single centre, qualitative study to understand concerns and supportive care needs of this novel survivor population. Methods: Eligible pts had mNSCLC, aged >18, English speaking and > 6 months post initiation of IT/TT without progressive disease. Semi-structured interviews were conducted focusing on physical, psychological, social and functional impacts of diagnosis, therapy and prognosis. Interviews were audio-recorded and transcribed. The framework method of analysis was used. Results: 20 pts were interviewed between May-December 2019; m..View full abstract